Trial Onboarding Meetings

Trial Onboarding Meetings

When new NIH Collaboratory Trials join the program, they are introduced to the Coordinating Center and its services at an onboarding meeting. The purpose of the onboarding meetings is to welcome and learn about the new trials, provide an overview of the NIH Pragmatic Trials Collaboratory, introduce investigators to the Core Working Groups, and engage in discussion. Materials from these meetings, including agendas and slides, are posted here for reference.

Featured Trials

CARNATION and EquiP PC

CARNATION and EquiP PC were welcomed into the NIH Pragmatic Trials Collaboratory in October of 2025. Both UG3 trials are supported by the National Institute of Neurological Disorders and Stroke through the Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) program, a component of the Helping to End Addiction Long-Term Initiative℠, or NIH HEAL Initiative℠, to address the opioid crisis.

Learn More

Completed Onboarding Materials

 

 

2025 Onboarding Meetings

  • October 29, 2025 Virtual Onboarding Meeting: CARNATION
    This onboarding meeting welcomed CARNATION, a new UG3 NIH Collaboratory Trial. Attendees provided introductions and an overview of the NIH Collaboratory program; heard from the new UG3 project team; and discussed lessons learned from the seasoned NIH Collaboratory Trials investigators.
  • October 28, 2025 Virtual Onboarding Meeting: EquiP PC
    This onboarding meeting welcomed EquiP PC, a new UG3 NIH Collaboratory Trial. Attendees provided introductions and an overview of the NIH Collaboratory program; heard from the new UG3 project team; and discussed lessons learned from the seasoned NIH Collaboratory Trials investigators.
  • January 8, 2025 Virtual Onboarding Meeting: STEP-2
    This onboarding meeting welcomed STEP-2, a new UG3 NIH Collaboratory Trial. Attendees provided introductions and an overview of the NIH Collaboratory program; heard from the new UG3 project team; and discussed lessons learned from the seasoned NIH Collaboratory Trials investigators.

2024 Onboarding Meetings

  • November 20, 2024 Virtual Onboarding Meeting: LungSMART
    This onboarding meeting welcomed LungSMART, a new UG3 NIH Collaboratory Trial. Attendees provided introductions and an overview of the NIH Collaboratory program; heard from the new UG3 project team; and discussed lessons learned from the seasoned NIH Collaboratory Trials investigators.
  • October 24, 2024 Virtual Onboarding Meeting: APA-SM
    This onboarding meeting welcomed APA-SM, a new UG3 NIH Collaboratory Trial. Attendees provided introductions and an overview of the NIH Collaboratory program; heard from the new UG3 project team; and discussed lessons learned from the seasoned NIH Collaboratory Trials investigators.

2023 Onboarding Meetings

2020 Onboarding Meetings

  • November 9, 2020 Virtual Onboarding Meeting: BeatPain Utah and GRACE
    This onboarding meeting welcomed 2 new PRISM UG3 NIH Collaboratory Trials: BeatPain Utah and GRACE. Attendees provided introductions and an overview of the NIH Collaboratory program; heard from the new UG3 project teams; and discussed lessons learned from the seasoned NIH Collaboratory Trials investigators.

2019 Onboarding Meetings

  • November 2019 Onboarding Meeting: NOHARM, OPTIMUM, FM TIPS, and AcuOA
    This onboarding meeting welcomed 4 new PRISM UG3 NIH Collaboratory Trials: NOHARM, OPTIMUM, FM TIPS, and AcuOA. Attendees provided introductions and an overview of the NIH Collaboratory program; heard from the new UG3 project teams; and discussed lessons learned from the seasoned NIH Collaboratory Trials investigators.

2018 Onboarding Meetings

2014 Onboarding Meetings

  • August 2014 Steering Committee and Onboarding Meeting: MCC Trials
    This combination steering committee and onboarding meeting welcomed 3 new Multiple Chronic Condition UH2 NIH Collaboratory Trials. Attendees provided introductions and an overview of the NIH Collaboratory program; heard from the new UH2 project teams; and discussed lessons learned from the seasoned NIH Collaboratory Trials investigators.